If you have held this fund for the past quarter, you no doubt saw a pretty nice jump as it handily outpaced both the index and its peer group. This outperformance came from a couple of sources including its significant global equity exposure, which is currently just under 50%. Another source of return came from its significant holdings in both Shoppers Drug Mart, and Loblaws. Both of those names rallied sharply thanks to the recent takeover news. While I have a lot of confidence in Daniel Dupont’s style, process and approach, I would strongly suggest that you take advantage of the recent gains and rebalance your portfolio, taking some profits off the table. For the long term, I still believe that this is a great core holding for most investors.